Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.36 |
| ▸ | STAT1 | P42224 | 1/20 | 0.36 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.31 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.30 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.30 |
| ▸ | CYCS | P99999 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8468859 | 0.81 | STAT3 (0.49) | STAT3STAT1 | |
| SCHEMBL20843737 | 0.81 | STAT3 (0.43) | STAT3STAT1ABCG2CYCS | |
| SCHEMBL8466680 | 0.80 | STAT3 (0.44) | STAT3STAT1 | |
| SCHEMBL28533125 | 0.75 | STAT3 (0.41) | STAT3STAT1 | |
| SCHEMBL6418846 | 0.74 | ABCG2 (0.50) | ABCG2TLR8CYCS | |
| SCHEMBL1596068 | 0.74 | STAT3 (0.47) | STAT3STAT1ABCG2CYCS | |
| SCHEMBL6412535 | 0.73 | ABCG2 (0.45) | STAT3STAT1ABCG2TLR8 | |
| SCHEMBL351526 | 0.72 | STAT3 (0.43) | STAT3STAT1ABCG2CYCS | |
| SCHEMBL1597373 | 0.72 | STAT3 (0.43) | STAT3STAT1ABCG2CYCS | |
| SCHEMBL6418943 | 0.72 | STAT3 (0.41) | STAT3STAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10450322-B2 | Low molecular weight derivatives of carboxamide halogenated porphyrins, namely chlorins and bacteriochlorins, and their applications thereof | LUZITIN, S.A. (PT) | 2019-10-22 | — | — | US | disclosed |
| EP-3292129-B1 | LOW MOLECULAR WEIGHT HALOGENATED PORPHYRINE CARBOXAMIDE CHLORIN AND BACTERIOCHLORIN DERIVATIVES FOR USE IN PHOTODYNAMIC THERAPY FOR TREATING CANCER | LUZITIN S A (PT) | 2019-03-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10450322-B2 | Low molecular weight derivatives of carboxamide halogenated porphyrins, namely chlorins and bacteriochlorins, and their applications thereof | CRY1, PPIA, PPOX | STAT3 361/4885STAT1 833/4885ABCG2 3063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.